Status:
ACTIVE_NOT_RECRUITING
HCC Innervation Assessment
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hepatocarcinoma
Eligibility:
All Genders
18-90 years
Brief Summary
Primary liver cancer casualties are ranked 3rd worldwide and are still on the rise despite the recent advent of adequate hepatitis B and C therapies. Genetic diseases of the liver and hepatic comorbid...
Eligibility Criteria
Inclusion
- Patients with hepatocarcinoma who undergo surgical resection or liver transplant
- Patients with and without treatment
Exclusion
- \- Pregnant or lactating women
- Minor patient
- Patient under legal protection measure or deprived of their liberty
Key Trial Info
Start Date :
June 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06886763
Start Date
June 30 2024
End Date
December 31 2029
Last Update
March 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupement hospitalier Sud, Hospices Civils de Lyon
France, Egypt, 69230
2
Groupement Hospitalier Nord, Hospices Civils de Lyon
France, France, 69004